{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Bacterial+Infection&page=5", "query": { "condition": "Oral Bacterial Infection", "page": 5 }, "page_size": 10 }, "pagination": { "page": 5, "page_size": 10, "total_count": 214, "total_pages": 22, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Bacterial+Infection&page=6&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Oral+Bacterial+Infection&page=4&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-07T06:32:12.441Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01610388", "title": "A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Infections, Bacterial" ], "interventions": [ { "name": "500mg IV GSK1322322/placebo", "type": "DRUG" }, { "name": "1000mg oral GSK1322322/placebo", "type": "DRUG" }, { "name": "1000mg IV GSK1322322/placebo", "type": "DRUG" }, { "name": "1500mg oral GSK1322322/placebo dose", "type": "DRUG" }, { "name": "1500mg IV GSK1322322/placebo", "type": "DRUG" }, { "name": "2000mg IV GSK1322322J/placebo", "type": "DRUG" }, { "name": "3000mg IV GSK1322322J/placebo", "type": "DRUG" }, { "name": "1000mg IV GSK1322322J/placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 61, "start_date": "2011-09-13", "completion_date": "2012-01-26", "has_results": false, "last_update_posted_date": "2017-06-12", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01610388" }, { "nct_id": "NCT00279864", "title": "The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Staphylococcal Infection", "Staphylococcus Aureus Prosthetic Joint Infection" ], "interventions": [], "intervention_types": [], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 15, "start_date": "2005-09", "completion_date": "2007-01", "has_results": false, "last_update_posted_date": "2015-04-30", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00279864" }, { "nct_id": "NCT05153499", "title": "A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Recurrent C. Difficile Infection" ], "interventions": [ { "name": "CP101", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Finch Research and Development LLC.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2021-11-15", "completion_date": "2023-02-24", "has_results": true, "last_update_posted_date": "2023-11-13", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 61, "location_summary": "Phoenix, Arizona • Mission Hills, California • Oakland, California + 51 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Mission Hills", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05153499" }, { "nct_id": "NCT06555328", "title": "Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Urticaria, Idiopathic", "Hidradenitis", "Hidradenitis Suppurativa" ], "interventions": [ { "name": "CSU lower dose treatment", "type": "DRUG" }, { "name": "CSU high dose treatment", "type": "DRUG" }, { "name": "CSU non responders IgE - high dose treatment", "type": "DRUG" }, { "name": "HS low dose treatment", "type": "DRUG" }, { "name": "HS medium dose treatment", "type": "DRUG" }, { "name": "HS high dose treatment", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "InflaRx GmbH", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 73, "start_date": "2025-01-02", "completion_date": "2026-01-22", "has_results": false, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 9, "location_summary": "Fountain Valley, California • North Miami Beach, Florida • Tampa, Florida + 6 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "North Miami Beach", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Murray", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT06555328" }, { "nct_id": "NCT06261840", "title": "Refining Treatment Options for Trichomonas Vaginalis Infection: A Comparative Analysis of Metronidazole and Secnidazole", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Trichomonas Vaginitis", "Bacterial Vaginitis" ], "interventions": [ { "name": "Metronidazole 500 mg", "type": "DRUG" }, { "name": "Secnidazole 2000 MG", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tulane University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1200, "start_date": "2025-05-06", "completion_date": "2029-07-31", "has_results": false, "last_update_posted_date": "2026-05-06", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 4, "location_summary": "Birmingham, Alabama • North Miami, Florida • New Orleans, Louisiana", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "North Miami", "state": "Florida" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT06261840" }, { "nct_id": "NCT00384397", "title": "A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Meningococcal Meningitis", "Measles", "Mumps", "Rubella", "Varicella" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "249 Days", "maximum_age": "305 Days", "sex": "ALL", "summary": "249 Days to 305 Days" }, "enrollment_count": 1128, "start_date": "2006-09", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-04-14", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 39, "location_summary": "Montgomery, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 35 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00384397" }, { "nct_id": "NCT00132327", "title": "Analysis of Lyme Disease Lesions", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Erythema Migrans Lesions", "Erythema Migrans" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2005-08-17", "completion_date": "2018-11-29", "has_results": false, "last_update_posted_date": "2018-12-03", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00132327" }, { "nct_id": "NCT00001027", "title": "A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-Sulfamethoxazole", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pneumonia, Pneumocystis Carinii", "HIV Infections" ], "interventions": [ { "name": "Pentamidine isethionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Month", "maximum_age": "6 Years", "sex": "ALL", "summary": "1 Month to 6 Years" }, "enrollment_count": 32, "start_date": null, "completion_date": "1996-09", "has_results": false, "last_update_posted_date": "2021-11-01", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 11, "location_summary": "Los Angeles, California • Oakland, California • Washington D.C., District of Columbia + 4 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Oakland", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001027" }, { "nct_id": "NCT00000717", "title": "The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii Pneumonia in Patients With AIDS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pneumonia, Pneumocystis Carinii", "HIV Infections" ], "interventions": [ { "name": "Primaquine", "type": "DRUG" }, { "name": "Clindamycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": null, "sex": "ALL", "summary": "13 Years and older" }, "enrollment_count": 50, "start_date": null, "completion_date": "1991-11", "has_results": false, "last_update_posted_date": "2012-10-19", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 7, "location_summary": "Los Angeles, California • San Francisco, California • Chicago, Illinois + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000717" }, { "nct_id": "NCT01552668", "title": "Fidaxomicin to Prevent Clostridium Difficile Colonization", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Clostridium Difficile Infection" ], "interventions": [ { "name": "Fidaxomicin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2012-09", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-05-28", "last_synced_at": "2026-10-07T06:32:12.441Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01552668" } ] }